Ultrafiltrate and total platinum in plasma and cerebrospinal fluid in a patient with neuroblastoma

Cancer Treat Rep. 1985 Dec;69(12):1441-2.

Abstract

Ultrafiltrate and total plasma and cerebrospinal fluid (CSF) platinum concentrations were examined in a patient with neuroblastoma following a 2-hour infusion of 120 mg/m2 of cisplatin. Total plasma platinum was 93.4% bound, while the ultrafiltrate of plasma accounted for the remaining 6.6%. The CSF ultrafiltrate resulted in equivalent concentrations of platinum to total CSF platinum. CSF concentrations were 2.9% of the total plasma platinum and 43.5% of the ultrafiltrate plasma platinum 2 hours after the end of the infusion.

Publication types

  • Case Reports
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Brain Neoplasms / drug therapy
  • Brain Neoplasms / metabolism*
  • Child, Preschool
  • Cisplatin / metabolism*
  • Cisplatin / therapeutic use
  • Humans
  • Male
  • Neuroblastoma / drug therapy
  • Neuroblastoma / metabolism*
  • Platinum / analysis*
  • Platinum / blood
  • Platinum / cerebrospinal fluid
  • Time Factors
  • Ultrafiltration

Substances

  • Platinum
  • Cisplatin